Press release
Investigation announced for Investors in shares of Vaccinex, Inc. (NASDAQ: VCNX)
An investigation for investors in Vaccinex, Inc. (NASDAQ: VCNX) shares over potential securities laws violations by Vaccinex, Inc.
Investors who purchased shares of Vaccinex, Inc. (NASDAQ: VCNX), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Vaccinex, Inc. (NASDAQ: VCNX) concerning whether a series of statements by Vaccinex, Inc regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
Rochester, NY based Vaccinex, Inc., a clinical-stage biotechnology company, discovers and develops bio therapeutics to treat serious diseases and conditions with unmet medical needs, including cancer, neurodegenerative diseases, and autoimmune disorders. On August 9, 2018, Vaccinex, Inc. announced the pricing for its initial public offering. Vaccinex, Inc sold 3.33 million shares at $12.00 per share. Since then shares of Vaccinex, Inc. (NASDAQ: VCNX) declined to as low as $3.94 per share on July 26, 2019.
Those who purchased shares of Vaccinex, Inc. (NASDAQ: VCNX) have certain options and should contact the Shareholders Foundation.
Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Investors in shares of Vaccinex, Inc. (NASDAQ: VCNX) here
News-ID: 1824099 • Views: …
More Releases from Shareholders Foundation
Lawsuit Alert: Investors who lost money with James Hardie Industries plc (NYSE: …
An investor, who purchased shares of James Hardie Industries plc (NYSE: JHX), filed a lawsuit over alleged violations of Federal Securities Laws by James Hardie Industries plc in connection with certain allegedly false and misleading statements.
Investors who purchased shares of James Hardie Industries plc (NYSE: JHX) have certain options and for certain investors are short and strict deadlines running. Deadline: December 23, 2025. NYSE: JHX investors should contact the Shareholders…
Investigation announced for Long-Term Investors in SelectQuote, Inc. (NYSE: SLQT …
An investigation on behalf of current long-term investors in shares of SelectQuote, Inc. (NYSE: SLQT) concerning potential breaches of fiduciary duties by certain directors and officers of SelectQuote, Inc. was announced.
Investors who are current long term investors in SelectQuote, Inc. (NYSE: SLQT) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term…
Lawsuit filed for Investors who lost money with shares of MoonLake Immunotherape …
An investor, who purchased shares of MoonLake Immunotherapeutics (NASDAQ: MLTX), filed a lawsuit over alleged violations of Federal Securities Laws by MoonLake Immunotherapeutics in connection with certain allegedly false and misleading statements.
Investors who purchased a significant amount of shares of MoonLake Immunotherapeutics (NASDAQ: MLTX) between March 10, 2024 and September 29, 2025, have certain options and for certain investors are short and strict deadlines running. Deadline: December 15, 2025. NASDAQ:…
Dow Inc. (NYSE: DOW) Investor Alert: Deadline in Lawsuit on October 28, 2025
A deadline is coming up on October 28, 2025 in the lawsuit filed for certain investors of Dow Inc. (NYSE: DOW) over alleged securities laws violations by Dow Inc.
Investors who purchased shares of Dow Inc. (NYSE: DOW) have certain options and there are strict and short deadlines running. Deadline: October 28, 2025. Dow Inc. (NYSE: DOW) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -…
More Releases for Vaccinex
Huntington's Disease Market to Evolve Rapidly Over the Next Decade by 2034, Delv …
The Key Huntington's Disease Companies in the market include - Teva Pharmaceutical, Annexon Biosciences, Prilenia Therapeutics, Neurocrine Biosciences, Som Biotech, Annexon Biosciences, Vaccinex, Sage Therapeutics, UniQure Biopharma, Roche, Ionis Pharmaceuticals, Neurocrine Biosciences, Vaccinex, Azevan Pharmaceuticals, WaVe life Sciences, Luye Pharma Group, SOLA Biosciences, and others.
DelveInsight's "Huntington's Disease Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Huntington's Disease, historical and forecasted epidemiology as well as the…
Huntington's Disease Market to Expand Significantly by 2034, States DelveInsight …
The Key Huntington's Disease Companies in the market include - Teva Pharmaceutical, Annexon Biosciences, Prilenia Therapeutics, Neurocrine Biosciences, Som Biotech, Annexon Biosciences, Vaccinex, Sage Therapeutics, UniQure Biopharma, Roche, Ionis Pharmaceuticals, Neurocrine Biosciences, Vaccinex, Azevan Pharmaceuticals, WaVe life Sciences, Luye Pharma Group, SOLA Biosciences, and others.
DelveInsight's "Huntington's Disease Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Huntington's Disease, historical and forecasted epidemiology as well as the…
Huntington's Disease Market Growth to Accelerate in Forecast Period (2024-2034), …
The Key Huntington's Disease Companies in the market include - Teva Pharmaceutical, Annexon Biosciences, Prilenia Therapeutics, Neurocrine Biosciences, Som Biotech, Annexon Biosciences, Vaccinex, Sage Therapeutics, UniQure Biopharma, Roche, Ionis Pharmaceuticals, Neurocrine Biosciences, Vaccinex, Azevan Pharmaceuticals, WaVe life Sciences, Luye Pharma Group, SOLA Biosciences, and others.
DelveInsight's "Huntington's Disease Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Huntington's Disease, historical and forecasted epidemiology as well as the…
The Market share for VX15 (Pepinemab) by Vaccinex, Inc. Set to Experience Tremen …
[Las Vegas, United States] DelveInsight, a leader in healthcare research firm, has recently published an in-depth report on VX15 (Pepinemab) (Vaccinex, Inc.) providing insights into the drug market landscape and market forecast of VX15 (Pepinemab) upto 2032. The report, titled "VX15 (pepinemab) Market Size, Forecast, and Emerging Insight - 2032" is now available for review and analysis.
Are you interested in finding out the projected market size of VX15 (Pepinemab)…
Huntington's Disease Market to Register Incremental Growth During the Forecast P …
DelveInsight's "Huntington's Disease Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Huntington's Disease, historical and forecasted epidemiology as well as the Huntington's Disease market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Huntington's Disease market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Huntington's Disease Market Forecast
https://www.delveinsight.com/sample-request/huntingtons-disease-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the…
Investigation announced for Long-Term Investors in shares of Vaccinex, Inc. (NAS …
An investigation was announced concerning potential breaches of fiduciary duties by certain officers and directors at Vaccinex, Inc..
Investors who purchased shares of Vaccinex, Inc. (NASDAQ: VCNX) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Vaccinex, Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders.
Rochester, NY based Vaccinex,…
